Just announced at the 2024 Ascend Rett National Conference, Health Canada has accepted regulatory applications from Acadia Pharmaceuticals for DayBue (Trofinetide), but has also been accepted for a priority review by Health Canada. We were honored to be… Read More
Hope Fund Research Update
Leave a Comment
Last Updated: 01/26/2025 by Steve
Priority Review by Health Canada
Leave a Comment
Last Updated: 01/23/2025 by Steve
Just announced at the 2024 Ascend Rett National Conference, Health Canada has accepted regulatory applications from Acadia Pharmaceuticals for DayBue (Trofinetide), but has also been accepted for a priority review by Health Canada. We were honored to be… Read More
2024 Research Grant Awarded
Leave a Comment
Last Updated: 11/13/2024 by Steve
The Board of Directors has unanimously approved the funding of two research grants totaling $100,000 from the Hope Fund for 2024. Both projects have strong scientific merit and show promise into future Rett research. The Hope Fund was… Read More